The SARS-CoV-2 Omicron recombinant subvariants XBB, XBB.1, and XBB.1.5 are expanding rapidly with unique mutations, antibody evasion, and immune escape properties – an alarming global threat of a surge in COVID-19 cases again?-Reference-Cited by-同舟云学术

The SARS-CoV-2 Omicron recombinant subvariants XBB, XBB.1, and XBB.1.5 are expanding rapidly with unique mutations, antibody evasion, and immune escape properties – an alarming global threat of a surge in COVID-19 cases again?

Published:2023-03-14 Issue:4 Volume:109 Page:1041-1043
ISSN:1743-9159
Container-title:International Journal of Surgery
language:en
Short-container-title:

Author:

Chakraborty Chiranjib¹^ORCID,Bhattacharya Manojit²,Chopra Hitesh³^ORCID,Islam Md. Aminul⁴⁵^ORCID,Saikumar Gutulla⁶^ORCID,Dhama Kuldeep⁶^ORCID

Affiliation:

1. Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, West Bengal

2. Department of Zoology, Fakir Mohan University, VyasaVihar, Balasore, Odisha

3. Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab

4. Advanced Molecular Lab, Department of Microbiology, President Abdul Hamid Medical College, Karimganj, Kishoreganj

5. COVID-19 Diagnostic Lab, Department of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh

6. Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,Surgery

Reference16 articles.

1. The rapid emergence of multiple sublineages of Omicron (B.1.1.529) variant: dynamic profiling via molecular phylogenetics and mutational landscape studies;Chakraborty;Journal of infection and public health,2022

2. Cases of BA.2.75 and recent BA.2.75.2 subvariant of Omicron are increasing in India: is it alarming at the global level?;Chakraborty;Ann Med Surg (Lond),2022

3. Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2;Qu;Cell host & microbe,2022

4. Renewed global threat by the novel SARS-CoV-2 variants ‘XBB, BF.7, BQ.1, BA.2.75, BA.4.6’: a discussion;Mohapatra;Frontiers in Virology,2022

5. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants;Wang;Cell,2022

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Divergent pathogenetic outcomes in BALB/c mice following Omicron subvariant infection;Virus Research;2024-03

2. Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain;Structure;2024-02

3. An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants;Journal of Controlled Release;2024-02

4. Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial;Vaccines;2024-01-24

5. SARS-CoV-2 variant-specific differences in inhibiting the effects of the PKR-activated integrated stress response;Virus Research;2024-01